AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Docs Who Lift
FLOW trial and GLP-1 cost rant
Jun 4, 2024
Drs. Karl and Spencer discuss the FLOW trial showing kidney protection with semaglutide, rant about costly medicines, compounding considerations, and the need for heart and kidney health focus in diabetes management.
45:30
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Semaglutide in the FLOW trial showed kidney protective effects.
- The podcast emphasizes the importance of diabetes medications in kidney protection.
Deep dives
Overview of the Flow Trial and Renal Outcomes
The podcast discusses the Flow Trial using Ozempic at one milligram and its findings on kidney outcomes, indicating its kidney protective effects. It highlights the increased risks of heart and kidney diseases associated with obesity and diabetes, emphasizing the significance of cardioreno focus in managing these complications.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode